Peninsula Pharmaceuticals' Series B Round

Peninsula Pharmaceuticals raised a round of funding on October 24, 2002.

Peninsula Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing antibiotics to treat life-threatening infections. The lead antibiotic candidate, Doripenem for inject…

Articles about Peninsula Pharmaceuticals' Series B Round: